Lumen Meds Review
Best for: patients prioritizing entity transparency, free cold shipping, and lifestyle-coaching support alongside compounded GLP-1 access
Lumen Meds (lumenmeds.com) is a Delaware-incorporated compounded GLP-1 telehealth platform (Lumen Meds LLC, 128 Sunset Blvd #1214, New Castle, DE 19720). LegitScript Approval #47534109. Promotional first-month pricing is shown as $0; ongoing tirzepatide pricing is $195.82/month. Programs include the doctor's visit, medication, free expedited cold shipping, ongoing doctor support, lifestyle coaching, and conditional lab orders.
Medium confidence · Last verified 2026-05-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Lumen Meds is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Lumen Meds prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Compounded semaglutide (first month promotional) | compounded | $0 |
| Compounded tirzepatide (ongoing) | compounded | $195.82 |
✓ Pros
- •Specific LegitScript Approval number (#47534109) publicly displayed — easier to independently verify than seal-only platforms
- •Free expedited COLD shipping disclosed — important for GLP-1 cold-chain integrity
- •Lifestyle coaching included in the program — not just medication dispensing
- •Conditional lab orders ('orders labs if needed') reflect a clinical-quality posture
- •Delaware LLC with named legal entity (Lumen Meds LLC) and physical address — better entity transparency than peer platforms
- •$195.82/month tirzepatide ongoing price sits in the cheapest decile of the US compounded-tirz market
✗ Cons
- •Promotional first-month $0 pricing requires careful attention to recurring billing terms (verify cancellation policy before committing)
- •Standard ongoing semaglutide price NOT disclosed publicly (only the first-month promo)
- •Per-state availability NOT enumerated publicly
- •Pharmacy partners NOT publicly named — material YMYL transparency gap
- •Health-quiz gate before pricing transparency — final per-patient pricing depends on the intake response
Ready to start with Lumen Meds?
Starting at $0/month. See current pricing and start your free consultation.
Sources & methodology
Our Lumen Meds review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Lumen Meds
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Lumen Meds?
Starting at $0/month. See current pricing and start your free consultation.